Keywords: واکسن آنتراکس; Pediatric medical countermeasure research; Anthrax vaccine; Presidential Ethics Committee; Children; AE; adverse events; AVA; anthrax vaccine adsorbed; BARDA; Biomedical Advanced Research and Development Authority; CDC; Centers for Disease Control and Pre
مقالات ISI واکسن آنتراکس (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: واکسن آنتراکس; BAP; benzyl amino purine; BC; before challenge titers; CFU; colony forming units; CT; cholera toxin; DMEM; Dulbecco's modified eagle medium; ELISA; enzyme linked immunosorbent assay; HRP; horseradish peroxidase; IBA; indole-3-butyric acid; i.p.; intraperi
Correlation between anthrax lethal toxin neutralizing antibody levels and survival in guinea pigs and nonhuman primates vaccinated with the AV7909 anthrax vaccine candidate
Keywords: واکسن آنتراکس; Animal rule; Correlate of protection; TNA threshold; Anthrax vaccine; CPG 7909 adjuvant; Guinea pig; Cynomolgus macaque;
Risk of disability for US army personnel vaccinated against anthrax, 1998–2005
Keywords: واکسن آنتراکس; Anthrax vaccine; Disability; Army
A combination of the TLR4 agonist CIA05 and alum promotes the immune responses to Bacillus anthracis protective antigen in mice
Keywords: واکسن آنتراکس; Anthrax vaccine; Bacillus anthracis protective antigen; Adjuvant; Toll-like receptor 4 agonist; Alum;
Evaluation of anthrax vaccine production by Bacillus anthracis Sterne 34F2 in stirred suspension culture using a miniature bioreactor: A useful scale-down tool for studies on fermentations at high containment
Keywords: واکسن آنتراکس; Bacillus anthracis Sterne 34F2; Miniature bioreactor; Anthrax vaccine; Protective Antigen (PA); Lethal Factor (LF)
The social, political, ethical, and economic aspects of biodefense vaccines
Keywords: واکسن آنتراکس; Biodefense; Smallpox vaccine; Anthrax vaccine; Bioterrorism
Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990–2007
Keywords: واکسن آنتراکس; Anthrax vaccine; Post-marketing surveillance; VAERS
Chimeric hepatitis B virus core particles carrying an epitope of anthrax protective antigen induce protective immunity against Bacillus anthracis
Keywords: واکسن آنتراکس; Anthrax protective antigen; HBc particles; Neutralizing epitope; Anthrax vaccine
Protection against anthrax by needle-free mucosal immunization with human anthrax vaccine
Keywords: واکسن آنتراکس; Anthrax vaccine; Bacillus anthracis; Mucosal immunization; Protective immunity
A comparative assessment of immunization records in the Defense Medical Surveillance System and the Vaccine Adverse Event Reporting System
Keywords: واکسن آنتراکس; Anthrax vaccine; Surveillance; Military immunization records
Immunization against anthrax using Bacillus subtilis spores expressing the anthrax protective antigen
Keywords: واکسن آنتراکس; Anthrax; Endospores; Anthrax vaccine; Heat-stable vaccine
Patterns of antibody response in humans to the anthrax vaccine adsorbed (AVA) primary (six-dose) series
Keywords: واکسن آنتراکس; Anthrax vaccine; Antibody; Antibody kinetics
Determination of benzethonium chloride in anthrax vaccine adsorbed by HPLC
Keywords: واکسن آنتراکس; Benzethonium chloride; HPLC; Anthrax vaccine
N-fragment of edema factor as a candidate antigen for immunization against anthrax
Keywords: واکسن آنتراکس; Anthrax vaccine; Edema factor; Protective immunity; Replication-incompetent adenovirus
Efficacy of non-toxic deletion mutants of protective antigen from Bacillus anthracis
Keywords: واکسن آنتراکس; Protective antigen; Deletion mutant; Bacillus anthracis; Anthrax vaccine;
Expression and secretion of the protective antigen of Bacillus anthracis in Bacillus brevis
Keywords: واکسن آنتراکس; Recombinant protective antigen; Bacillus brevis; Bacillus anthracis; Anthrax vaccine;
Appropriation and commercialization of the Pasteur anthrax vaccine
Keywords: واکسن آنتراکس; Anthrax vaccine; Know-how; Intellectual property rights; Licensing agreements;